2"-O-β-D-glucopyranosyl eucommiol | 82225-01-2

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: 2"-O-β-D-glucopyranosyl eucommiol
• 英文别名: eucommioside I；eucommioside；(2R,3R,4S,5S,6R)-2-[2-[(1R,5R)-5-hydroxy-2,3-bis(hydroxymethyl)cyclopent-2-en-1-yl]ethoxy]-6-(hydroxymethyl)oxane-3,4,5-triol
• CAS: 82225-01-2
• 化学式: C₁₅H₂₆O₉
• 分子量: 350.366
• InChiKey: VYACBHCRZHLZIT-UUQQTNGRSA-N

物化性质

• 沸点：
  655.0±55.0 °C(Predicted)
• 密度：
  1.52±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  -4
• 重原子数：
  24
• 可旋转键数：
  7
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.87
• 拓扑面积：
  160
• 氢给体数：
  7
• 氢受体数：
  9

反应信息

• 作为反应物：
  描述：

  2"-O-β-D-glucopyranosyl eucommiol 在 β-glucosidase 作用下， 以 various solvent(s) 为溶剂， 反应 1.0h， 以30 mg的产率得到杜仲醇
  参考文献：
  名称：

  杜仲中杜仲苷（2″-O-β-d-吡喃葡萄糖基杜仲）的结构解析

  摘要：

  摘要 描述了从杜仲中分离杜仲苷的方法。化学修饰和光谱证据将杜仲苷确定为杜仲醇的 2"-O-β-d-吡喃葡萄糖基衍生物，杜仲醇是一种先前从同一植物中分离出来的已知环戊烯四醇。

  DOI：

  10.1016/0031-9422(82)80043-5
• 作为产物：
  描述：

  hepta-O-acetyleucommioside 在 barium dihydroxide 作用下， 以 甲醇 为溶剂， 以45 mg的产率得到2"-O-β-D-glucopyranosyl eucommiol
  参考文献：
  名称：

  杜仲中杜仲苷（2″-O-β-d-吡喃葡萄糖基杜仲）的结构解析

  摘要：

  摘要 描述了从杜仲中分离杜仲苷的方法。化学修饰和光谱证据将杜仲苷确定为杜仲醇的 2"-O-β-d-吡喃葡萄糖基衍生物，杜仲醇是一种先前从同一植物中分离出来的已知环戊烯四醇。

  DOI：

  10.1016/0031-9422(82)80043-5

文献信息

• Deyama; Ikawa; Kitagawa, Chemical and Pharmaceutical Bulletin, 1986, vol. 34, # 12, p. 4933 - 4938
  作者：Deyama、Ikawa、Kitagawa、Nishibe

  DOI：——

  日期：——
• SYNERGISTIC ANTI-HYPERTENSIVE PHYTO-NUTRACEUTICAL COMPOSITION
  申请人：OLALDE RANGEL JOSE ANGEL

  公开号：US20080267939A1

  公开（公告）日：2008-10-30

  A Phyto-nutraceutical composition for the prevention and treatment of hypertensive disorders is provided. A specific combination of extracts of plants and nutraceuticals is provided, based on categorizing plants and nutraceuticals into one of three groups, Energy, Bio-Intelligence, and Organization. Such combinations have synergistic effects, with minimal side effect.
• Iridoid Based Formulations
  申请人：West Brett Justin

  公开号：US20110217394A1

  公开（公告）日：2011-09-08

  Embodiments of the invention relate to fortified food and dietary supplement products which may be administered to produce desirable physiological improvement. In particular, embodiments of the invention relates to the administration of products enhanced with plant products and iridoids.
• Acai and Iridoid Based Formulations
  申请人：West Brett Justin

  公开号：US20110206786A1

  公开（公告）日：2011-08-25

  Embodiments of the invention relate to fortified food and dietary supplement products, which may be administered to produce desirable physiological improvement. In particular, embodiments of the invention relate to the administration of products enhanced with Acai and iridoids.
• Morinda Citrifolia and Iridoid Based Formulations
  申请人：West Brett Justin

  公开号：US20110206787A1

  公开（公告）日：2011-08-25

  Embodiments of the invention relate to fortified food and dietary supplement products which may be administered to produce desirable physiological improvement. In particular, embodiments of the invention relates to the administration of products enhanced with Morinda citrifolia and iridoids.